Eupraxia Pharmaceuticals (EPRX) Assets (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) recorded Assets of $139.91 million in the quarter ended Jun 30, 2026, up 492.9% from $23.6 million a year earlier but down 3.7% from the prior quarter.
Eupraxia Pharmaceuticals (EPRX) Assets (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Eupraxia Pharmaceuticals reported Assets of $86.15 million, up 146.5% from the prior year.
- Annual Assets has increased for three straight years, with a three-year compound annual growth rate of 65.2% (years ended Dec 2022 to Dec 2025).
- Across earlier years, Assets came in at $34.94 million in the year ended Dec 31, 2024 (+72.4%), $20.27 million in the year ended Dec 31, 2023 (+6.0%) and $19.12 million in the year ended Dec 31, 2022.
- Quarterly Assets has ranged from $10.36 million in the quarter ended Sep 30, 2024 to $145.35 million in the quarter ended Mar 31, 2026 over the past five years.
- On a year-over-year basis, Assets has increased for four consecutive quarters, with growth averaging 267.8% over the last seven quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 791.0% in the quarter ended Sep 30, 2025, against a decline of 20.2% in the quarter ended Mar 31, 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $145.35 million (quarter ended Mar 31, 2026), $86.15 million (quarter ended Dec 31, 2025) and $92.35 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Eupraxia Pharmaceuticals | 328.04 Mn | 326.44 Mn | - | 139.91 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 139.91 Mn |
| Mar 31, 2026 | 145.35 Mn |
| Dec 31, 2025 | 86.15 Mn |
| Sep 30, 2025 | 92.35 Mn |
| Jun 30, 2025 | 23.60 Mn |
| Mar 31, 2025 | 29.23 Mn |
| Dec 31, 2024 | 34.94 Mn |
| Sep 30, 2024 | 10.36 Mn |
| Jun 30, 2024 | 24.98 Mn |
| Mar 31, 2024 | 36.64 Mn |
| Dec 31, 2023 | 20.27 Mn |
| Dec 31, 2022 | 19.12 Mn |
Eupraxia Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=EPRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();